Christopher Wingard
Final Settlement Approved in New England Biolabs ESOP Case
On August 7, 2025, a federal district judge in Massachusetts approved a $7,150,000 class settlement for former New England Biolabs, Inc. employees who alleged that the company’s redemption of their ESOP shares was completed at an unfairly low price.